Dr Edward W Boyts, MD | |
68370 Clinton Street, Post Office Box 48, New Paris, IN 46553 | |
(574) 831-5440 | |
(574) 831-6922 |
Full Name | Dr Edward W Boyts |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 34 Years |
Location | 68370 Clinton Street, New Paris, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750351086 | NPI | - | NPPES |
100086430 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 01036932A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Goshen Hospital | Goshen, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Goshen Health System Inc | 4880598572 | 132 |
News Archive
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
Manganese dioxide could make the preparation of micromotors increasingly cost-effective, opening up new avenues for their use, according to a new study from the University of Eastern Finland.
A device that could help decrease the global burden of unwanted pregnancy has been invented by University of Otago academics.
Researchers in the U.S. say many mental disorders afflicting millions of Americans are often evident in adolescence but usually go untreated for years.
› Verified 3 days ago
Entity Name | Goshen Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194772293 PECOS PAC ID: 4880598572 Enrollment ID: O20031124000658 |
News Archive
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
Manganese dioxide could make the preparation of micromotors increasingly cost-effective, opening up new avenues for their use, according to a new study from the University of Eastern Finland.
A device that could help decrease the global burden of unwanted pregnancy has been invented by University of Otago academics.
Researchers in the U.S. say many mental disorders afflicting millions of Americans are often evident in adolescence but usually go untreated for years.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Edward W Boyts, MD 68370 Clinton Street, Post Office Box 48, New Paris, IN 46553 Ph: (574) 831-5440 | Dr Edward W Boyts, MD 68370 Clinton Street, Post Office Box 48, New Paris, IN 46553 Ph: (574) 831-5440 |
News Archive
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
Manganese dioxide could make the preparation of micromotors increasingly cost-effective, opening up new avenues for their use, according to a new study from the University of Eastern Finland.
A device that could help decrease the global burden of unwanted pregnancy has been invented by University of Otago academics.
Researchers in the U.S. say many mental disorders afflicting millions of Americans are often evident in adolescence but usually go untreated for years.
› Verified 3 days ago